Commonwealth Of Pennsylvania Public School Empls Retrmt Sys Eagle Pharmaceuticals, Inc. Transaction History

Commonwealth Of Pennsylvania Public School Empls Retrmt Sys

$15.5 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$25.06 - $34.09 $2,982 - $4,056	-119 Reduced 1.07%	11,025 $312,000
Q4 2022 Feb 13, 2023	BUY	$24.98 - $39.77 $36,495 - $58,103	1,461 Added 15.09%	11,144 $326,000
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $13,315 - $23,748	-504 Reduced 4.95%	9,683 $256,000
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $16,091 - $20,026	390 Added 3.98%	10,187 $453,000
Q1 2022 May 12, 2022	BUY	$44.58 - $52.6 $53,852 - $63,540	1,208 Added 14.06%	9,797 $485,000
Q4 2021 Feb 11, 2022	SELL	$45.82 - $56.9 $6,873 - $8,535	-150 Reduced 1.72%	8,589 $437,000
Q3 2021 Nov 10, 2021	SELL	$43.79 - $55.78 $9,371 - $11,936	-214 Reduced 2.39%	8,739 $487,000
Q2 2021 Aug 12, 2021	BUY	$36.86 - $44.5 $368 - $445	10 Added 0.11%	8,953 $383,000
Q1 2021 May 12, 2021	SELL	$40.32 - $50.97 $1,612 - $2,038	-40 Reduced 0.45%	8,943 $373,000
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $17,272 - $21,254	-414 Reduced 4.41%	8,983 $418,000
Q3 2020 Nov 12, 2020	BUY	$37.02 - $51.28 $159,148 - $220,452	4,299 Added 84.33%	9,397 $399,000
Q2 2020 Aug 11, 2020	BUY	$43.24 - $55.02 $345 - $440	8 Added 0.16%	5,098 $245,000
Q1 2020 May 14, 2020	BUY	$34.37 - $60.07 $57,054 - $99,716	1,660 Added 48.4%	5,090 $234,000
Q4 2019 Feb 11, 2020	BUY	$54.32 - $64.31 $186,317 - $220,583	3,430 New	3,430 $206,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Of Pennsylvania Public School Empls Retrmt Sys with notifications on news.

Account